CD248 activates TGF-β receptor I to promote vascular remodeling in pulmonary arterial hypertension
L. Jones, Hannah J. McIntire-Ray, Angela N. Morales, Shia Vang, Meghan June Hirsch, Andres J Gonzalez Coba, Emma Lea Matthews, Katherine L. Adriatico, Nicholas P Harris, Iram Zafar, D Xing, Vivian Y. Lin, Liping Tian, Gregory A. Payne, Aftab M. Ahmad, , Jarrod Wesley Barnes
This study identifies CD248 as a co-activator of TGF-β receptor I in pulmonary arterial hypertension, supporting anti-CD248 therapy as a targeted alternative to systemic TGF-β inhibition.
bioRxiv · Apr 29, 2026 · PreprintMolecular Biology